Directed chemotherapy delivery for leptomeningeal metastases

Ended Cooperative Agreement Awarded Last action

Award ID
R41CA206744
Recipient
Awarding agency
Obligated
$224,970

Award facts

Assistance listing
93.395 Cancer Treatment Research
Completion date
Originally
Place of performance
Minnesota, USA

Award details come from USAspending.gov.

Transactions

Action Obligated Date
Amendment $0
Amendment $0
Original award $224,970

Quick answers

Who received award R41CA206744?

R41CA206744 was awarded to Minnetronix, Inc. by National Cancer Institute (National Institutes of Health) on September 1, 2016.

How much is award R41CA206744 worth?

$224,970 has been obligated on R41CA206744.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award